KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) EBT Margin (2016 - 2025)

Historic EBT Margin for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to 29.95%.

  • Dynavax Technologies' EBT Margin rose 53700.0% to 29.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.29%, marking a year-over-year decrease of 215700.0%. This contributed to the annual value of 11.13% for FY2024, which is 130100.0% up from last year.
  • Per Dynavax Technologies' latest filing, its EBT Margin stood at 29.95% for Q3 2025, which was up 53700.0% from 22.23% recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' EBT Margin ranged from a high of 51.56% in Q4 2021 and a low of 143.59% during Q1 2025
  • For the 5-year period, Dynavax Technologies' EBT Margin averaged around 7.19%, with its median value being 20.35% (2023).
  • As far as peak fluctuations go, Dynavax Technologies' EBT Margin surged by 10482100bps in 2021, and later tumbled by -1209500bps in 2025.
  • Over the past 5 years, Dynavax Technologies' EBT Margin (Quarter) stood at 51.56% in 2021, then decreased by -29bps to 36.84% in 2022, then tumbled by -95bps to 1.79% in 2023, then soared by 491bps to 10.59% in 2024, then skyrocketed by 183bps to 29.95% in 2025.
  • Its EBT Margin was 29.95% in Q3 2025, compared to 22.23% in Q2 2025 and 143.59% in Q1 2025.